Aktive Positionen von Brian A. Pryor
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
LiteCure LLC
 LiteCure LLC Medical SpecialtiesHealth Technology LiteCure LLC manufactures and distributes medical devices. Its products include LightForce EX, LightForce Pro, LCT-1000, Compass and Empower DS. The firm is a registered manufacturer providing FDA cleared products for a variety of medical applications. The company was founded by Brian A. Pryor and Sean X. Wang in October 2007 and is headquartered in Newark, DE. | Vorstandsvorsitzender | 01.01.2007 | - |
| Gründer | 27.01.2010 | - | |
| Präsident | 01.01.2007 | - | |
Nanospectra Biosciences, Inc.
 Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Brian A. Pryor
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Chief Executive Officer | 1 |
| Founder | 1 |
| President | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
LiteCure LLC
LiteCure LLC Medical SpecialtiesHealth Technology LiteCure LLC manufactures and distributes medical devices. Its products include LightForce EX, LightForce Pro, LCT-1000, Compass and Empower DS. The firm is a registered manufacturer providing FDA cleared products for a variety of medical applications. The company was founded by Brian A. Pryor and Sean X. Wang in October 2007 and is headquartered in Newark, DE. | Health Technology |
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |
- Börse
- Insiders
- Brian A. Pryor
- Erfahrung
